NRC Health (NRC): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$30.21M
Year ended 2025-12-31
$23.37M
Trailing 12 months to 2026-06-30
-0.1%
10-year compound annual growth
$48.57M2009-12-31: $17.53M2010-12-31: $18.56M2011-12-31: $23.80M2012-12-31: $27.42M2013-12-31: $28.54M2014-12-31: $32.10M2015-12-31: $30.56M2016-12-31: $35.42M2017-12-31: $38.80M2018-12-31: $40.74M2019-12-31: $48.57M2023-12-31: $45.94M2024-12-31: $41.22M2025-12-31: $30.21M$30.21M
2009-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$30.21M-26.7%2026-03-05, From 2025-01-01
2024-12-31$41.22M-10.3%2026-03-05, From 2024-01-01
2023-12-31$45.94Mn/a2026-03-05, From 2023-01-01
No annual figure between 2019-12-31 and 2023-12-31.
2019-12-31$48.57M+19.2%2022-03-04, From 2019-01-01
2018-12-31$40.74M+5.0%2021-03-05, From 2018-01-01
2017-12-31$38.80M+9.6%2020-03-06, From 2017-01-01
2016-12-31$35.42M+15.9%2019-03-08, From 2016-01-01
2015-12-31$30.56M-4.8%2018-03-14, From 2015-01-01
2014-12-31$32.10M+12.5%2017-03-03, From 2014-01-01
2013-12-31$28.54M+4.1%2016-03-04, From 2013-01-01
2012-12-31$27.42M+15.2%2015-03-04, From 2012-01-01
2011-12-31$23.80M+28.2%2014-03-04, From 2011-01-01
2010-12-31$18.56M+5.9%2013-03-01, From 2010-01-01
2009-12-31$17.53Mn/a2012-03-01, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
NRC Health (NRC)2025-12-31$30.21M-26.7%
MaxCyte, Inc. (MXCT)2025-12-31-$47.56Mn/m
OmniAb, Inc. (OABI)2025-12-31-$47.22Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$9.73Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.07Mn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27$428.47M-27.3%
Incyte Corp (INCY)2025-12-31$1.61B+967.7%
Absci Corp (ABSI)2025-12-31-$108.58Mn/m
Icon PLC (ICLR)2025-12-31$825.84M-45.7%

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗